Melanotan II 10mg

Melanotan II was initially created as a potential preventative treatment for various types of skin cancer. The idea was that by artificially triggering the body's tanning process in individuals at high risk for developing skin cancer due to sun exposure, it might reduce their likelihood of acquiring the disease later in life.

In addition to offering a tan without needing excessive sun exposure and enhancing sexual performance and desire, Melanotan II may also aid in appetite reduction by targeting a receptor in the brain that suppresses hunger. While this effect is not overwhelming, it is noticeable for most users and is considered beneficial by many. The length of time that the tanning effect lasts after a user stops taking the drug will depend on various factors, but most users typically observe that the tan fades and becomes less visible within four to eight weeks after discontinuing the drug.

For most people in the loading phase with the hormone, a dosage of 0.015 to 0.02 milligrams per kilogram of body weight per injection should be adequate. These injections may occur anywhere from twice a day to as seldom as every other day or longer. During the maintenance phase, many individuals find that a dose of about 0.01 milligrams per kilogram of body weight, administered once every few days, is sufficient to sustain the hormone's effects.